Daxor Corporation (NYSE:DXR)
Industry: Medical Instruments & Supplies

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

Current Quote*
Last: $13.000
Change: 1.000
Book: $2.445
Volume: 14,339

As Of: 11/20 16:09 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol DXR

Graphs for DXR


3 Month Graph


6 Month Graph


1 Year Graph